
Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2019 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 35 stocks in 2019 Q1, with total market value around $11.90B.
Baupost Group's top five holdings in 2019 Q1: EBAY INC. COM(EBAY) 9.14%, VIASAT INC(VSAT) 8.94%, FOX CORP - CLASS A(FOXA) 8.43%, LIBERTY GLOBAL PLC SHS CL C(LBTYA) 7.95%, CHENIERE ENERGY INC 7.25%.
- Portfolio Value
- $11.90B
- Current Holdings
- 35 stocks
- New / Increased
- 8 / 10
- Reduced / Exited
- 5 / 10
Current Holdings
| 1 | EBAY INC. COMEBAY | 1.09 | 9.14% | 29.29 +39.46% | $37.14 | - | $30.64 | +8.29 | 0.50 | +$0.19B+21.23% | Increased |
| 2 | VIASAT INCVSAT | 1.06 | 8.94% | 13.73 - | $77.50 | - | $70.34 | 0.00 | 6.00 | +$0.10B+10.19% | Held |
| 3 | FOX CORP - CLASS AFOXA | 1.00 | 8.43% | 27.32 | $36.71 | - | $36.71 | +27.32 | 0.25 | $0.00B0.00% | New |
| 4 | LIBERTY GLOBAL PLC SHS CL CLBTYA | 0.95 | 7.95% | 39.09 +31.44% | $24.21 | - | $12.93 | +9.35 | 0.75 | +$0.44B+87.21% | Increased |
| 5 | CHENIERE ENERGY INCCUSIP 16411R208 | 0.86 | 7.25% | 12.62 -11.11% | $68.36 | - | $64.49 | -1.58 | 5.25 | +$0.05B+6.01% | Reduced |
| 6 | QORVO INCCUSIP 74736K101 | 0.76 | 6.38% | 10.59 -0.86% | $71.73 | - | $67.34 | -0.09 | 2.25 | +$0.05B+6.52% | Reduced |
| 7 | ALLERGAN PFD CONV SER ACUSIP G0177J108 | 0.70 | 5.87% | 4.77 +0.30% | $146.41 | - | $212.79 | +0.01 | 3.25 | -$0.32B-31.19% | Increased |
| 8 | Synchrony FinancialSYF | 0.45 | 3.82% | 14.26 -2.01% | $31.90 | $72.84 +128.34% | $29.47 | -0.29 | 2.75 | +$0.62B+147.16% | Reduced |
| 9 | P G & E CORPPCG | 0.44 | 3.66% | 24.50 +58.33% | $17.80 | - | $29.62 | +9.03 | 1.25 | -$0.29B-39.91% | Increased |
| 10 | CBS CORP NEW CL BCUSIP 124857202 | 0.41 | 3.41% | 8.54 +235.37% | $47.53 | - | $46.39 | +5.99 | 0.50 | +$0.01B+2.45% | Increased |
| 11 | CELGENE CORPCUSIP 151020104 | 0.38 | 3.17% | 4.00 | $94.34 | - | $94.34 | +4.00 | 0.25 | $0.00B0.00% | New |
| 12 | MCKESSON CORP COMMCK | 0.33 | 2.77% | 2.82 +63.66% | $117.06 | $742.44 +534.24% | $135.75 | +1.09 | 1.75 | +$1.71B+446.92% | Increased |
| 13 | TESLA INC CV SR UNSEC NTCUSIP 88160RAD3可转换债券 | 0.33 | 2.76% | 300.00 - | $1.09 | - | $1.16 | 0.00 | 1.25 | -$0.02B-5.83% | Held |
| 14 | PIONEER NAT RES COCUSIP 723787107 | 0.30 | 2.56% | 2.00 -55.52% | $152.28 | - | $167.62 | -2.50 | 1.75 | -$0.03B-9.15% | Reduced |
| 15 | COLONY CAP INC NEWCUSIP 19626G108 | 0.26 | 2.22% | 49.69 - | $5.32 | - | $6.24 | 0.00 | 1.00 | -$0.05B-14.74% | Held |
| 16 | ATARA BIOTHERAPEUTICS INCCUSIP 046513107 | 0.25 | 2.13% | 6.38 +2.01% | $39.75 | - | $33.00 | +0.13 | 4.50 | +$0.04B+20.45% | Increased |
| 17 | ANTERO RES CORPCUSIP 03674X106 | 0.25 | 2.12% | 28.59 - | $8.83 | - | $16.39 | 0.00 | 4.75 | -$0.22B-46.14% | Held |
| 18 | TAKEDA PHARMACEUTICAL CO LTDCUSIP 874060205 | 0.22 | 1.83% | 10.67 | $20.37 | - | $20.37 | +10.67 | 0.25 | $0.00B0.00% | New |
| 19 | THERAVANCE BIOPHARMA INCCUSIP G8807B106 | 0.21 | 1.77% | 9.31 - | $22.67 | - | $30.35 | 0.00 | 5.00 | -$0.07B-25.31% | Held |
| 20 | UNIVAR INC COMCUSIP 91336L107 | 0.21 | 1.77% | 9.50 - | $22.16 | - | $6.92 | 0.00 | 0.75 | +$0.14B+220.25% | Held |
| 21 | FOX CORP - CLASS BFOX | 0.20 | 1.71% | 5.68 | $35.88 | - | $35.88 | +5.68 | 0.25 | $0.00B0.00% | New |
| 22 | AKEBIA THERAPEUTICS INCCUSIP 00972D105 | 0.20 | 1.68% | 24.47 - | $8.19 | - | $5.53 | 0.00 | 0.50 | +$0.07B+48.10% | Held |
| 23 | AMERISOURCEBERGEN CORPCUSIP 03073E105 | 0.19 | 1.61% | 2.40 +19.36% | $79.52 | - | $88.34 | +0.39 | 1.75 | -$0.02B-9.99% | Increased |
| 24 | BRISTOL-MYERS SQUIBB COBMY | 0.19 | 1.60% | 4.00 | $47.71 | - | $47.71 | +4.00 | 0.25 | $0.00B0.00% | New |
| 25 | LIBERTY GLOBAL PLC SHS CL ALBTYA | 0.12 | 1.04% | 4.96 - | $24.92 | - | $28.93 | 0.00 | 0.75 | -$0.02B-13.86% | Held |
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2019 Q1.
| 1 | TWENTY FIRST CENTY FOX INC CL AFOXA | 51.28 | 3.50 | $38.45 | $48.12 | +$0.50B+25.15% |
| 2 | TWENTY FIRST CENTY FOX INC CL BCUSIP 90130A200 | 17.04 | 3.50 | $35.68 | $47.78 | +$0.21B+33.90% |
| 3 | YPF SA COMMON STOCKYPF | 6.00 | 0.50 | $15.45 | $13.39 | -$0.01B-13.33% |
| 4 | SHIRE PLCCUSIP 82481R106 | 0.46 | 0.75 | $172.92 | $174.04 | +$0.00B+0.65% |
| 5 | CARDINAL HEALTH INCCAH | 1.47 | 2.25 | $67.25 | $44.60 | -$0.03B-33.68% |
| 6 | AMC ENTMT HLDGS INCCUSIP 00165C104 | 1.46 | 1.50 | $14.81 | $12.28 | -$0.00B-17.11% |
| 7 | SENTINEL ENERGY SVCS INCCUSIP 81728P204 | 1.60 | 0.25 | $10.30 | $10.30 | $0.00B0.00% |
| 8 | NEXEO SOLUTIONS INCCUSIP 65342H110 | 10.00 | 0.50 | $0.58 | $0.40 | -$0.00B-30.90% |
| 9 | GTY TECHNOLOGY HOLDINGS INCCUSIP G4182A128 | 1.47 | 0.25 | $0.78 | $0.78 | $0.00B0.00% |
| 10 | SABAN CAP ACQUISITION CORPCUSIP 78516C114 | 1.16 | 2.25 | $0.95 | $0.60 | -$0.00B-36.84% |
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.